Enzo Other Stockholder Equity vs Total Assets Analysis

ENZ Stock  USD 0.99  0.02  1.61%   
Enzo Biochem financial indicator trend analysis is much more than just examining Enzo Biochem latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enzo Biochem is a good investment. Please check the relationship between Enzo Biochem Other Stockholder Equity and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Other Stockholder Equity vs Total Assets

Other Stockholder Equity vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enzo Biochem Other Stockholder Equity account and Total Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between Enzo Biochem's Other Stockholder Equity and Total Assets is 0.3. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Assets in the same time period over historical financial statements of Enzo Biochem, assuming nothing else is changed. The correlation between historical values of Enzo Biochem's Other Stockholder Equity and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Enzo Biochem are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Other Stockholder Equity i.e., Enzo Biochem's Other Stockholder Equity and Total Assets go up and down completely randomly.

Correlation Coefficient

0.3
Relationship DirectionPositive 
Relationship StrengthVery Weak

Other Stockholder Equity

Total Assets

Total assets refers to the total amount of Enzo Biochem assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enzo Biochem books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Enzo Biochem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enzo Biochem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enzo Biochem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.At this time, Enzo Biochem's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 54.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit42.0M11.6M14.6M13.9M
Total Revenue107.1M31.1M31.9M63.1M

Enzo Biochem fundamental ratios Correlations

0.050.250.320.830.49-0.54-0.150.670.21-0.10.81-0.180.470.020.140.260.30.230.420.9-0.590.010.10.420.47
0.05-0.27-0.24-0.440.410.550.66-0.050.460.790.02-0.55-0.550.97-0.14-0.03-0.620.860.23-0.14-0.45-0.380.36-0.57-0.58
0.25-0.270.510.190.11-0.41-0.360.3-0.19-0.250.3-0.490.26-0.260.010.480.20.050.40.270.33-0.48-0.070.350.36
0.32-0.240.510.180.51-0.11-0.710.020.42-0.60.060.120.74-0.420.510.20.750.260.440.180.190.20.510.70.73
0.83-0.440.190.180.11-0.77-0.330.65-0.12-0.390.720.170.57-0.430.10.160.46-0.340.120.87-0.380.25-0.20.530.58
0.490.410.110.510.110.36-0.35-0.170.87-0.14-0.01-0.280.450.270.670.540.360.630.820.1-0.3-0.080.630.430.44
-0.540.55-0.41-0.11-0.770.360.14-0.860.610.25-0.78-0.05-0.340.490.350.0-0.250.440.16-0.80.1-0.020.49-0.35-0.37
-0.150.66-0.36-0.71-0.33-0.350.140.24-0.240.950.22-0.38-0.860.77-0.63-0.44-0.90.33-0.38-0.01-0.33-0.34-0.27-0.88-0.9
0.67-0.050.30.020.65-0.17-0.860.24-0.430.190.95-0.250.110.0-0.48-0.05-0.040.01-0.050.88-0.41-0.18-0.360.10.11
0.210.46-0.190.42-0.120.870.61-0.24-0.43-0.08-0.30.00.280.280.720.160.30.60.55-0.19-0.180.220.740.180.22
-0.10.79-0.25-0.6-0.39-0.140.250.950.19-0.080.19-0.55-0.80.88-0.51-0.27-0.870.52-0.15-0.04-0.38-0.5-0.19-0.8-0.83
0.810.020.30.060.72-0.01-0.780.220.95-0.30.19-0.280.160.07-0.370.0-0.020.110.030.96-0.56-0.17-0.250.150.16
-0.18-0.55-0.490.120.17-0.28-0.05-0.38-0.250.0-0.55-0.280.35-0.630.16-0.540.5-0.54-0.55-0.120.070.920.150.250.28
0.47-0.550.260.740.570.45-0.34-0.860.110.28-0.80.160.35-0.660.620.340.97-0.170.390.39-0.020.380.210.980.99
0.020.97-0.26-0.42-0.430.270.490.770.00.280.880.07-0.63-0.66-0.260.01-0.760.760.18-0.11-0.45-0.510.17-0.65-0.67
0.14-0.140.010.510.10.670.35-0.63-0.480.72-0.51-0.370.160.62-0.260.380.660.10.62-0.150.190.260.280.560.58
0.26-0.030.480.20.160.540.0-0.44-0.050.16-0.270.0-0.540.340.010.380.20.10.840.080.11-0.56-0.020.470.44
0.3-0.620.20.750.460.36-0.25-0.9-0.040.3-0.87-0.020.50.97-0.760.660.2-0.260.270.220.140.530.250.920.94
0.230.860.050.26-0.340.630.440.330.010.60.520.11-0.54-0.170.760.10.1-0.260.470.01-0.35-0.360.53-0.2-0.2
0.420.230.40.440.120.820.16-0.38-0.050.55-0.150.03-0.550.390.180.620.840.270.470.120.02-0.460.210.430.44
0.9-0.140.270.180.870.1-0.8-0.010.88-0.19-0.040.96-0.120.39-0.11-0.150.080.220.010.12-0.54-0.01-0.210.360.39
-0.59-0.450.330.19-0.38-0.30.1-0.33-0.41-0.18-0.38-0.560.07-0.02-0.450.190.110.14-0.350.02-0.54-0.09-0.180.020.01
0.01-0.38-0.480.20.25-0.08-0.02-0.34-0.180.22-0.5-0.170.920.38-0.510.26-0.560.53-0.36-0.46-0.01-0.090.330.250.29
0.10.36-0.070.51-0.20.630.49-0.27-0.360.74-0.19-0.250.150.210.170.28-0.020.250.530.21-0.21-0.180.330.160.18
0.42-0.570.350.70.530.43-0.35-0.880.10.18-0.80.150.250.98-0.650.560.470.92-0.20.430.360.020.250.160.99
0.47-0.580.360.730.580.44-0.37-0.90.110.22-0.830.160.280.99-0.670.580.440.94-0.20.440.390.010.290.180.99
Click cells to compare fundamentals

Enzo Biochem Account Relationship Matchups

Enzo Biochem fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets112.5M113.7M95.9M121.9M85.8M100.6M
Short Long Term Debt Total32.8M22.7M20.6M7.0M3.5M3.3M
Other Current Liab10.3M8.1M8.2M34.5M22.5M23.6M
Total Current Liabilities32.8M26.1M24.6M40.0M24.8M15.1M
Total Stockholder Equity58.4M68.6M54.5M78.5M56.1M74.8M
Property Plant And Equipment Net34.4M33.6M32.4M16.7M15.2M12.5M
Net Debt(15.1M)9.2M(1.0M)(75.4M)(48.9M)(46.4M)
Retained Earnings(278.3M)(270.4M)(288.6M)(268.4M)(294.4M)(279.7M)
Cash47.9M13.5M21.6M82.4M52.4M42.5M
Non Current Assets Total43.8M43.1M41.5M23.4M15.7M14.9M
Non Currrent Assets Other1.4M1.8M1.6M1.7M530K503.5K
Cash And Short Term Investments47.9M43.5M21.6M82.4M52.4M46.6M
Net Receivables9.1M10.2M4.8M4.8M4.0M3.8M
Common Stock Shares Outstanding47.7M48.3M48.6M49.2M50.9M37.4M
Liabilities And Stockholders Equity112.5M113.7M95.9M121.9M85.8M100.6M
Non Current Liabilities Total21.4M19.0M16.8M3.4M4.9M7.8M
Inventory7.8M12.7M15.4M7.9M6.8M5.6M
Other Current Assets4.0M4.2M6.9M3.3M6.8M7.2M
Other Stockholder Equity334.5M337.1M339.5M344.4M348.1M220.0M
Total Liab54.2M45.1M41.4M43.4M29.7M18.8M
Property Plant And Equipment Gross34.4M33.6M63.9M34.0M32.0M33.6M
Total Current Assets68.8M70.6M54.4M98.5M70.0M68.6M
Accumulated Other Comprehensive Income1.7M1.4M3.2M1.9M1.9M2.0M
Intangible Assets1.0M538K244K7.5M6.7M6.7M
Accounts Payable8.5M8.1M3.7M3.6M1.4M1.3M
Short Term Debt11.5M7.2M1.1M2.0M917K871.2K
Common Stock Total Equity476K479K485K487K560.1K422.6K
Common Stock479K485K487K499K521K433.3K
Other Assets1.4M1.8M1.6M6.7M6.0M6.3M
Property Plant Equipment14.5M33.6M17.3M16.7M19.2M10.2M
Current Deferred Revenue(391K)2.5M2.7M11.7M5.9M3.7M
Long Term Debt4.5M4.4M4.1M269K189K179.6K
Net Tangible Assets50.4M60.9M47.0M78.5M90.2M58.6M
Retained Earnings Total Equity(252.2M)(249.7M)(278.3M)(288.6M)(259.8M)(272.8M)
Capital Surpluse334.5M337.1M339.5M344.4M396.1M359.7M
Non Current Liabilities Other424K16.9M5K12.8M14.7M15.4M
Short Long Term Debt7.1M152K229K2.6M76K72.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.